Company: VCYT
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001384101-25-000060
Chunk: 27

Company: VERACYTE, INC.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 27
---
,000 (36,484)53,516 90,000 (34,234)55,766 6Decipher trade names4,000 (3,243)757 4,000 (3,043)957 1C2i developed technology25,300 (1,967)23,333 25,300 (1,546)23,754 14Total finite-lived intangibles139,420 (53,826)85,594 139,420 (50,619)88,801 8.3In-process research and development13,500 — 13,500 13,500 — 13,500 Total intangible assets$152,920 $(53,826)$99,094 $152,920 $(50,619)$102,301 Acquisition-related intangibles are generally finite-lived and are carried at cost less accumulated amortization. Amortization of the finite-lived intangible assets is recognized on a straight-line basis over their estimated lives, which approximates the pattern in which the economic benefits of the intangible assets are expected to be realized. Amortization expense of $3.2 million and $3.7 million was recognized for the three months ended March 31, 2025 and 2024, respectively.The estimated future aggregate amortization expense as of March 31, 2025 is as follows (in thousands of dollars):Year Ending December 31,Amounts2025 remainder of year$9,621 202612,185 202712,028 202812,028 202912,028 Thereafter27,704 Total$85,594  Supplies and InventorySupplies consisted of lab supplies and reagents to be used in the performance of testing services. Inventory related to finished and semi-finished goods used in the assembly of diagnostic kits related to product sales as well as raw materials consumed in the contract manufacturing process. As of March 31, 2025 and December 31, 2024, supplies and inventory consisted of the following (in thousands of dollars): March 31, 2025December 31, 2024Supplies$18,360 $17,876 Inventory5,894 3,874 Total supplies and inventory$24,254 $21,750 

12

Accrued LiabilitiesAccrued liabilities consisted of the following (in thousands of dollars):